Feed Insights Top Reports Pricing

⌘K

16:04:05·1788d

SECFilingvia Quantisnow

SEC Form 10-Q filed by uniQure N.V.

ByQuantisnow·Wall Street's wire, on your screen.

QURE· uniQure N.V.

Health Care

Plus alert sent

Quantisnow Plus members were alerted at 16:04:07 ET - 2.6s after publication.

Sign up for Plus

Free Quantisnow account

Get notified the moment QURE files

Real-time alerts on SEC filings, FDA approvals, analyst ratings, insider trades, and press releases. Follow any ticker. No credit card.

Sign up free Log in

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track QURE (uniQure N.V.) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

SEC Form 144 filed by uniQure N.V.
uniQure upgraded by Barclays with a new price target
SEC Form 144 filed by uniQure N.V.
Director Balachandran Madhavan exercised 10,000 units of Ordinary Shares at a strike of $8.49 and sold $278,500 worth of Ordinary Shares (10,000 units at $27.85) as part of a pre-agreed trading plan (SEC Form 4)
Chief Legal Officer Potts Jeannette sold $144,908 worth of Ordinary Shares (5,237 units at $27.67), decreasing direct ownership by 4% to 133,246 units (SEC Form 4) to satisfy tax liability

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022